Astrazeneca plc

NASDAQ: AZN
$76.41
+$0.53 (+0.7%)
Closing price May 1, 2024
AstraZeneca is a global biopharmaceutical giant, dedicated to the discovery, development, and commercialization of prescription medicines. Its portfolio spans a wide range of areas including cardiovascular, renal, metabolism, oncology, and treatments for rare diseases and COVID-19. The company is known for leading products like Tagrisso, Imfinzi, and Lynparza, among others. AstraZeneca not only serves healthcare professionals and patients worldwide but also engages in significant collaborations, such as with Neurimmune AG, to push the boundaries of medicine. Headquartered in Cambridge, UK, AstraZeneca continues to be at the forefront of addressing global health challenges.

AstraZeneca Cuts Almost All Ties to Inovio Pharma
Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Alcoa, Broadcom, Disney, Dow, Lyft, Netflix, Roku, Wingstop, Xilinx and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Broadcom, Dow, Lyft, Netflix, Roku, Walt Disney, Wingstop and Xilinx.
Jon C. Ogg
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Amazon, CarMax, Celgene, Chevron, Exxon, Lyft, FedEx, Peabody Energy, UPS, Wells Fargo and More
The top analyst upgrades, downgrades and initiations seen on Monday included Amazon.com, CarMax, Celgene, Chevron, Exxon Mobil, Lyft, FedEx, Peabody Energy, UPS and Wells Fargo.
Jon C. Ogg
Published:
Last Updated:

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Trey Thoelcke
Published:
Last Updated:

Major 2019 Biopharma Catalysts Coming in February and March
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Chris Lange
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software, Valero Energy and More
The top analyst upgrades, downgrades and initiations seen on Friday included Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software and Valero Energy.
Lee Jackson
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron...
Lee Jackson
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More
  Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see numerous waves of selling in...
Jon C. Ogg
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: AVEO, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon, Macy's, Sysco, Teladoc and More
The include top analyst upgrades, downgrades and initiations seen from Thursday AVEO Pharmaceuticals, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon Athletica, Macy's, Sysco and Teladoc...
Jon C. Ogg
Published:
Last Updated:

5 Merrill Lynch Equity Income Stocks With Huge Total Return Potential
These five top growth companies are all rated Buy and pay outstanding dividends, and they have good growth prospects.
Lee Jackson
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More
Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.
Lee Jackson
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: American Water Works, JB Hunt, Ford, GM, AstraZeneca and More
The top analyst upgrades, downgrades and other research calls from Friday include American Water Works, JB Hunt, Ford, General Motors and AstraZeneca.
Jon C. Ogg
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Alcoa, American Airlines, Equifax, Mindbody, Tiffany, Tyler Technologies and More
The top analyst upgrades, downgrades and other research calls from Friday include Alcoa, American Airlines, Equifax, Mindbody, Tiffany and Tyler Technologies.
Lee Jackson
Published:
Last Updated:

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
Jon C. Ogg
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Arch Coal, Editas, FireEye, Generac, NextEra, Under Armour and More
The top analyst upgrades, downgrades and other research calls from Thursday include Arch Coal, Editas Medicine, FireEye, Generac, NextEra Energy and Under Armour.
Jon C. Ogg
Published:
Last Updated: